Pin‐Jung Chen

934 total citations
19 papers, 399 citations indexed

About

Pin‐Jung Chen is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Pin‐Jung Chen has authored 19 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Pin‐Jung Chen's work include Cancer Genomics and Diagnostics (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Prostate Cancer Treatment and Research (3 papers). Pin‐Jung Chen is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Prostate Cancer Treatment and Research (3 papers). Pin‐Jung Chen collaborates with scholars based in United States, Taiwan and Iran. Pin‐Jung Chen's co-authors include Hsian‐Rong Tseng, Pai‐Chi Teng, Ju Dong Yang, Joseph Ahn, Edwin M. Posadas, Shelly C. Lu, Yazhen Zhu, Richard S. Finn, Shuang Hou and Yi‐Te Lee and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and International Immunology.

In The Last Decade

Pin‐Jung Chen

15 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pin‐Jung Chen United States 6 166 158 149 141 70 19 399
Pai‐Chi Teng United States 7 173 1.0× 215 1.4× 143 1.0× 239 1.7× 89 1.3× 15 506
Hye Ri Ahn South Korea 11 71 0.4× 214 1.4× 113 0.8× 232 1.6× 85 1.2× 16 409
Dinglan Zuo China 14 100 0.6× 193 1.2× 187 1.3× 249 1.8× 90 1.3× 25 534
Xi Ai China 10 90 0.5× 80 0.5× 101 0.7× 163 1.2× 40 0.6× 24 361
Liling Qin China 10 158 1.0× 127 0.8× 92 0.6× 136 1.0× 47 0.7× 20 366
Liye Tao China 9 59 0.4× 124 0.8× 93 0.6× 170 1.2× 55 0.8× 26 353
Yunxing Shi China 10 68 0.4× 123 0.8× 145 1.0× 178 1.3× 82 1.2× 17 386
Junhao Zheng China 9 61 0.4× 223 1.4× 118 0.8× 292 2.1× 62 0.9× 30 492
Chen-Yu Hu China 12 85 0.5× 126 0.8× 43 0.3× 214 1.5× 41 0.6× 19 371
Xiaoxue Ren China 6 118 0.7× 133 0.8× 35 0.2× 234 1.7× 40 0.6× 9 373

Countries citing papers authored by Pin‐Jung Chen

Since Specialization
Citations

This map shows the geographic impact of Pin‐Jung Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pin‐Jung Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pin‐Jung Chen more than expected).

Fields of papers citing papers by Pin‐Jung Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pin‐Jung Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pin‐Jung Chen. The network helps show where Pin‐Jung Chen may publish in the future.

Co-authorship network of co-authors of Pin‐Jung Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Pin‐Jung Chen. A scholar is included among the top collaborators of Pin‐Jung Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pin‐Jung Chen. Pin‐Jung Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chen, Pin‐Jung, Alexander Kuo, Walid S. Ayoub, et al.. (2025). Clinical outcome after complete response with immunotherapy in hepatocellular carcinoma.. Journal of Clinical Oncology. 43(4_suppl). 573–573.
2.
Chen, Pin‐Jung, Alexandra Gangi, Kevin Waters, et al.. (2025). Chemopreventive strategies for sporadic colorectal cancer: a narrative review. Translational Gastroenterology and Hepatology. 10. 11–11. 1 indexed citations
3.
Min, Ji Hye, Pin‐Jung Chen, Touseef Ahmad Qureshi, et al.. (2025). Prediction of Immunotherapy Response in Hepatocellular Carcinoma Patients Using Pretreatment CT Images. Diagnostics. 15(16). 2090–2090.
4.
Rezaee‐Zavareh, Mohammad Saeid, et al.. (2024). Novel Biomarkers for Early Detection of Hepatocellular Carcinoma. Diagnostics. 14(20). 2278–2278. 9 indexed citations
5.
Chen, Pin‐Jung, et al.. (2024). Paeonol Derivative, 6′-Methyl Paeonol, Attenuates Aβ-Induced Pathophysiology in Cortical Neurons and in an Alzheimer’s Disease Mice Model. ACS Chemical Neuroscience. 15(4). 724–734. 2 indexed citations
6.
Chen, Pin‐Jung, et al.. (2024). FIRM-Tree: A Multidimensional Index Structure for Reprogrammable Flash Memory. IEEE Transactions on Computer-Aided Design of Integrated Circuits and Systems. 43(11). 3600–3613. 1 indexed citations
8.
Kulkarni, Ajinkya, et al.. (2023). High dose methotrexate (MTX) treatment: Value of post treatment MTX level monitoring and risk factors for acute kidney injury.. Journal of Clinical Oncology. 41(16_suppl). e19539–e19539. 3 indexed citations
9.
Lin, Yung‐Chang, Pin‐Jung Chen, Chien‐Hao Huang, et al.. (2023). Murine cytotoxic CD4+ T cells in the tumor microenvironment are at a hyper-maturation stage of Th1 CD4+ T cells sustained by IL-12. International Immunology. 35(8). 387–400. 1 indexed citations
11.
Chen, Pin‐Jung, et al.. (2021). NCU-NLP at ROCLING-2021 Shared Task: Using MacBERT Transformers for Dimensional Sentiment Analysis.. International Conference on Computational Linguistics. 380–384. 1 indexed citations
13.
Court, Colin M., Shuang Hou, Lian Liu, et al.. (2020). Somatic copy number profiling from hepatocellular carcinoma circulating tumor cells. npj Precision Oncology. 4(1). 16–16. 12 indexed citations
14.
Teng, Pai‐Chi, Yu Jen Jan, Jie‐Fu Chen, et al.. (2020). Prostate cancer CTC-RNA Assay: A new method for contemporary genomics and precision medicine via liquid biopsy.. Journal of Clinical Oncology. 38(6_suppl). 170–170. 1 indexed citations
15.
Winograd, Paul, Shuang Hou, Colin M. Court, et al.. (2020). Hepatocellular Carcinoma–Circulating Tumor Cells Expressing PD‐L1 Are Prognostic and Potentially Associated With Response to Checkpoint Inhibitors. Hepatology Communications. 4(10). 1527–1540. 82 indexed citations
16.
Ahn, Joseph, Pai‐Chi Teng, Pin‐Jung Chen, et al.. (2020). Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma. Hepatology. 73(1). 422–436. 261 indexed citations
17.
Teng, Pai‐Chi, Yu Jen Jan, Minhyung Kim, et al.. (2020). Development of a circulating tumor cell-based RNA classifier for patients with castration-resistant prostate cancer: CTC-PCS/PAM50.. Journal of Clinical Oncology. 38(15_suppl). e17509–e17509. 1 indexed citations
18.
Teng, Pai‐Chi, Yu Jen Jan, Junhee Yoon, et al.. (2019). A circulating tumor cell specific RNA assay for assessment of androgen receptor signaling inhibitor sensitivity in metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. 37(15_suppl). 5059–5059. 1 indexed citations
19.
Chen, Pin‐Jung, Pai‐Chi Teng, Yazhen Zhu, et al.. (2019). Noninvasive Prenatal Diagnostics: Recent Developments Using Circulating Fetal Nucleated Cells. Current Obstetrics and Gynecology Reports. 8(1). 1–8. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026